Table 4.
Guidance for choosing a TKI in the presence of comorbidities
 |
| |
Adapted with permission (Michael Deininger, Department of Internal Medicine and the Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, written communication, June 2017).